Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
Disagree. French market is driving this, has been since day 1. Most of our gains have been in anticipation of news.
The french market have been told this evening they are looking to test 500,000 from 11th May. We have approval
I think a lot will be looking to jump in before then, starting tomorrow! Just in case anyone missed it.... 6th April RNS:
Novacyt announces that the CNR (Centre National de Référence des Virus des Infections Respiratoires (dont la grippe)) of the Institut Pasteur, an internationally renowned centre for biomedical research with a goal of improving public health in France, has approved its COVID-19 test. The Company's CE-Mark test is available for immediate distribution into the French market.
Graham Mullis, Chief Executive Officer of Novacyt, commented:
"As an Anglo-French company, I am delighted that Novacyt is able to support both of its domestic markets in tackling this pandemic. The Institut Pasteur's evaluation and approval of our COVID-19 test is an important validation and I am grateful to Atothis, our distribution partner in France, for its efforts in working with the centre. We look forward to supporting the French authorities in their COVID-19 testing requirements."
Agree TomV,
The dPCR test launched in May will put an end to the reagent shortage and in all honesty is going to change the face of testing not just in the UK but the world.
However, he added that it would be unsurprising if quality had been affected by supply chain issues and shortages of qualified testing staff in hospital microbiology labs.
Problems like the quote below from The Guardian article will become a thing of the past:
“We almost certainly left it too late to buy a lot of these reagents,” he said. “It’s a bit like the NHS worker who goes to the supermarket to find all the shelves empty. We didn’t expect to be doing anywhere near as much of this stuff.”
Who I wonder was the first approved test. Some firm called PrimerDesign apparently who are part of a Anglo French biotech called Novacyt. Oh.. hang on a minute!!
Looks like May is going to be a VERY busy period!!
Who I wonder was the first approved test. Some firm called PrimerDesign apparently who are part of a Anglo French biotech called Novacyt. Oh.. hang on a minute!!
Looks like May is going to be a VERY busy period!!
Correct. NCYT test is a commercial CE IVD mark test.
The PHE test isn't as good. A whistleblower from PHE has leaked this to the guardian to make a story
End results is likely that PHE will continue to use their in-house test but also more pressure on them to purchase gold standard tests from PrimerDesign.
Do people read articles before posting?
In simple terms, that article is GREAT news for the likes of Novacyt.
PHE have their own "in house" that they were rolling out across the UK in the very early days.
They they purchased test kits from us. 115,000 to be precise. That is what the article refers to as "commercial kits".
Proof in the comment that PHE disputed the claim saying it's the same quality as other CE marked assays (i.e PrimerDesign test kit)
PHE disputed this, with a spokesperson saying: “There is no evidence to support that commercial tests are more accurate than the current PHE test. We believe the performance is comparable to currently available CE-marked assays [tests].”
From the 30/03 RNS.. more good news to come
"The Middle-East is becoming the strongest selling region, with orders of £1.6m (€1.8m) received in less than two weeks. The Company expects to sign further distribution partnerships during the next few weeks in this region and also expects to update on its progress in the US market following Emergency Use Authorization granted by the US Food and Drug Administration announced on 23 March 2020."
It's time for any serious investors to stop focusing (almost obsessing) on sales updates and read the last RNS again.
It is clear to me that the company is now being driven by manufacturing, not updating the market with every EUA, £1m+ order we receive. I think we can be safe in the knowledge that we are selling everything we make based on the fact we are looking to DOUBLE the number of tests from 4 to 8m whilst continuing to look for other third party manufacturers to yet further increase...!
Instead, I'd personally look to focus on the "direct-to-PCR" extraction method and the significance of this to the future of COVID19 testing, testing in the UK.
The first we heard of this new extraction methodology was in the previous RNS. Why is it important?
1. This removes the need for some scarce reagents
2. Significantly reduces the number of extraction steps
3. Allows for faster cycle times, higher throughputs and cost savings
What does Graham and the directors think of it?
"The Directors believe this innovation should facilitate an INCREASE IN TESTING CAPACITY for COVID-19, removing a current bottleneck in sample processing for laboratories."
Reading the above extract, I wouldn't be surprised if it includes GSK & AstraZeneca involvement to generate the national interest and help us scale up.
I also expect this to therefore be Government endorsed and expect a big push in the weeks ahead from the media and Matt Han**** etc, especially off the back of the recent news from the WHO that casts doubt over the reliability of AB tests.
Picture the first week of May, selling 8m tests per month and just about to launch a new extraction method for PCR testing with backing of key players and Government...
Sit back, hold your shares and enjoy the ride!
That's an old tweet. Check the latest valuation!!!....
https://twitter.com/GMF782/status/1244743952802201601?s=19
£6/7 a share is definitely achievable here guys
Competition does not matter everyone!!!
There needs to be MORE diagnostic providers to meet the global demand. We don't need to capitalise the entire diagnostic market to be successful. A small slice of the pie is enough. Don't be greedy!!
Cepheid might b a great tool but looks like you can only use on their own equipment? Good luck to them and anyone else that is providing reliable tests to help tackle this evil virus.
Novacyt are on their way to become a mid tier pharma and truly global brand. Whether you're in or not!.....
Everyone is focusing on FDA approval, don't forget we have signed a "major" distribution deal with two mainland territories outside mainland china. Both of these will be RNS'd.
South Korea / Japan perhaps?
Look at linkedin. PrimerDesign Head of R&D confirming in comments that it has been validated to use on Roche PCR equipment.
JV surely to be announced very soon. Anyone selling now then good luck. You'll need it.
Can @PHE_uk confirm the wait time for results once tested?
Info released from those tested claim the wait time is min 24h for results. In others it appears 48-72 hrs +
Why so long when other tests like @PrimerdesignLtd can provide in 2 hours? @NHSEngland
Second case confirmed in San Diego
#NCYT testing kit required in the US. Currently with FDA under EUA approval process.
https://amp.scmp.com/news/china/article/3050352/coronavirus-second-confirmed-case-among-evacuees-san-diego-quarantine?__twitter_impression=true
Recent news coming out of the U.S. NY Times / NBC news etc.
https://www.nbcnews.com/news/world/coronavirus-updates-more-cruise-ship-cases-confirmed-death-toll-continues-n1135606
https://www.nytimes.com/2020/02/12/health/coronavirus-test-kits-cdc.html
Puts focus back onto Novacyt and the requirement for specific testing of the 2019 stain.
FDA approval cannot be far away.